Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
  • HIPAA Compliant
  • ISO 27001 Certified

Status:

Lead Sponsor:

No Sponsor

Collaborating Sponsors:

No Collaborator

Conditions:

No Condition

Eligibility:

All genders

Above 18+

Phase:

1/4

Participant Compensation:

n/a

Eligibility Criteria

Inclusion

    Exclusion

      Key Trial Info

      Start Date :

      Trial Type :

      Clinical Trial

      End Date :

      Estimated Enrollment :

      Patients enrolled

      Trial Details

      Trial ID

      Active Locations (0)

      Enter a location and click search to find clinical trials sorted by distance.

      Page 1 of 0 (0 locations)

      No Results Found

      We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

      Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1. | DecenTrialz